Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Accepts healthy volunteers Results available

CONtrolled Focal Fibrous Band Release Method Study

ClinicalTrials.gov ID: NCT04743635

Public ClinicalTrials.gov record NCT04743635. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 7:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study to evaluate the safety and effectiveness of the Avéli medical device to reduce the appearance of cellulite.

Study identification

NCT ID
NCT04743635
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Revelle Aesthetics, Inc
Industry
Enrollment
74 participants

Conditions and interventions

Conditions

Interventions

Device

Eligibility (public fields only)

Age range
21 Years to 55 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 6, 2021
Primary completion
Jun 13, 2021
Completion
Mar 3, 2022
Last update posted
Jun 5, 2023

2021 – 2022

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
7
Facility City State ZIP Site status
Clinical Site #3 Los Angeles California 90292
Clinical Site #5 San Diego California 92121
Clinical Site #4 San Francisco California 94102
Clinical Site #2 Coral Gables Florida 33146
Clinical Site #6 Shreveport Louisiana 71105
Clinical Site #8 Chestnut Hill Massachusetts 02467
Clinical Site #1 Minneapolis Minnesota 55441

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04743635, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 5, 2023 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04743635 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →